Free Trial

Elimelech Rosner Sells 58,000 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

HealthEquity logo with Medical background

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) EVP Elimelech Rosner sold 58,000 shares of HealthEquity stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the transaction, the executive vice president now directly owns 75,689 shares in the company, valued at approximately $8,519,553.84. This trade represents a 43.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

HealthEquity Price Performance

Shares of NASDAQ HQY traded down $0.88 during trading on Thursday, hitting $103.68. 448,079 shares of the company were exchanged, compared to its average volume of 833,733. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $116.65. The company has a market cap of $8.97 billion, a price-to-earnings ratio of 95.12, a PEG ratio of 1.60 and a beta of 0.49. The firm's fifty day moving average price is $92.93 and its 200 day moving average price is $97.88.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. The firm had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. During the same quarter in the previous year, the firm earned $0.80 earnings per share. On average, sell-side analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Arcadia Investment Management Corp MI acquired a new stake in HealthEquity in the 4th quarter valued at about $26,000. Versant Capital Management Inc purchased a new stake in shares of HealthEquity in the first quarter valued at about $28,000. WPG Advisers LLC purchased a new stake in shares of HealthEquity in the first quarter valued at about $28,000. Transce3nd LLC acquired a new stake in shares of HealthEquity in the fourth quarter valued at approximately $29,000. Finally, Smartleaf Asset Management LLC increased its stake in shares of HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on HQY. Deutsche Bank Aktiengesellschaft upped their price objective on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, June 5th. Wells Fargo & Company upped their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. KeyCorp lowered their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price objective for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. Finally, The Goldman Sachs Group raised their target price on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 4th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $118.09.

View Our Latest Stock Report on HQY

About HealthEquity

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines